Finance

Lists
688513:SHA
Chengdu Easton Biopharmaceuticals Co Ltd
45,39 CN¥
-1,33%
(-0,61) 1D
16 հոկ, 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688513...
Open
46,49 CN¥
High
48,45 CN¥
Low
45,18 CN¥
Mkt. cap
8,01 մլրդ
Avg. vol.
1,91 մլն
Volume
2,01 մլն
Dividend
1,08%
Quarterly dividend
0,12 CN¥
Ex-dividend date
02 հնս, 2026 թ.
P/E ratio
28,35
52-wk high
80,48 CN¥
52-wk low
40,25 CN¥
EPS
1,60 CN¥
No. of employees
1 հզր
Open
46,49 CN¥
High
48,45 CN¥
Low
45,18 CN¥
Mkt. cap
8,01 մլրդ
Avg. vol.
1,91 մլն
Volume
2,01 մլն
Dividend
1,08%
Quarterly dividend
0,12 CN¥
Ex-dividend date
02 հնս, 2026 թ.
P/E ratio
28,35
52-wk high
80,48 CN¥
52-wk low
40,25 CN¥
EPS
1,60 CN¥
No. of employees
1 հզր
News stories
From web sources and news partners
About Chengdu Easton Biopharmaceuticals Co Ltd
CEO-
Employees1,42 հզր
Founded01 հնս, 2009 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
364,69 մլն
312,26 մլն
326,26 մլն
332,64 մլն
Cost of goods sold
87,18 մլն
88,47 մլն
73,62 մլն
82,94 մլն
Cost of revenue
87,18 մլն
88,47 մլն
73,62 մլն
82,94 մլն
Research and development expenses
54,95 մլն
79,44 մլն
72,66 մլն
77,99 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
136,71 մլն
128,80 մլն
143,86 մլն
107,14 մլն
Operating expense
197,59 մլն
214,09 մլն
212,02 մլն
195,99 մլն
Total operating expenses
284,77 մլն
302,56 մլն
285,64 մլն
278,93 մլն
Operating income
79,91 մլն
9,70 մլն
40,62 մլն
53,71 մլն
Other non operating income
-228,90 հզր
230,85 հզր
-519,09 հզր
493,27 հզր
EBT including unusual items
92,35 մլն
57,56 մլն
47,40 մլն
86,84 մլն
EBT excluding unusual items
79,77 մլն
51,53 մլն
41,48 մլն
54,72 մլն
Income tax expense
8,76 մլն
4,15 մլն
4,12 մլն
18,02 մլն
Effective tax rate
9,49%
7,21%
8,69%
20,75%
Other operating expenses
4,49 մլն
8,00 մլն
-4,46 մլն
11,52 մլն
Net income
83,59 մլն
63,90 մլն
50,83 մլն
78,92 մլն
Net profit margin
22,92%
20,46%
15,58%
23,73%
Earnings per share
-
-
-
-
Interest and investment income
733,65 հզր
42,65 մլն
1,95 մլն
2,46 մլն
Interest expense
-615,69 հզր
-622,07 հզր
-575,93 հզր
-792,69 հզր
Net interest expenses
117,96 հզր
42,02 մլն
1,38 մլն
1,67 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
100,25 մլն
32,44 մլն
63,37 մլն
81,43 մլն
Gain or loss from assets sale
-
-29,35 հզր
-
-18,53 հզր
AI content may include mistakes. Learn more
Google Apps